Cargando…
Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector
In recent years, the Orf virus has become a promising tool for protective recombinant vaccines and oncolytic therapy. However, suitable methods for an Orf virus production, including up- and downstream, are very limited. The presented study focuses on downstream processing, describing the evaluation...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403136/ https://www.ncbi.nlm.nih.gov/pubmed/32763261 http://dx.doi.org/10.1016/j.jbiotec.2020.07.023 |
_version_ | 1783566889651273728 |
---|---|
author | Lothert, Keven Pagallies, Felix Feger, Thomas Amann, Ralf Wolff, Michael W. |
author_facet | Lothert, Keven Pagallies, Felix Feger, Thomas Amann, Ralf Wolff, Michael W. |
author_sort | Lothert, Keven |
collection | PubMed |
description | In recent years, the Orf virus has become a promising tool for protective recombinant vaccines and oncolytic therapy. However, suitable methods for an Orf virus production, including up- and downstream, are very limited. The presented study focuses on downstream processing, describing the evaluation of different chromatographic unit operations. In this context, ion exchange-, pseudo-affinity- and steric exclusion chromatography were employed for the purification of the cell culture-derived Orf virus, aiming at a maximum in virus recovery and contaminant depletion. The most promising chromatographic methods for capturing the virus particles were the steric exclusion- or salt-tolerant anion exchange membrane chromatography, recovering 84 % and 86 % of the infectious virus. Combining the steric exclusion chromatography with a subsequent Capto™ Core 700 resin or hydrophobic interaction membrane chromatography as a secondary chromatographic step, overall virus recoveries of up to 76 % were achieved. Furthermore, a complete cellular protein removal and a host cell DNA depletion of up to 82 % was possible for the steric exclusion membranes and the Capto™ Core 700 combination. The study reveals a range of possible unit operations suited for the chromatographic purification of the cell culture-derived Orf virus, depending on the intended application, i.e. a human or veterinary use, and the required purity. |
format | Online Article Text |
id | pubmed-7403136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74031362020-08-05 Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector Lothert, Keven Pagallies, Felix Feger, Thomas Amann, Ralf Wolff, Michael W. J Biotechnol Article In recent years, the Orf virus has become a promising tool for protective recombinant vaccines and oncolytic therapy. However, suitable methods for an Orf virus production, including up- and downstream, are very limited. The presented study focuses on downstream processing, describing the evaluation of different chromatographic unit operations. In this context, ion exchange-, pseudo-affinity- and steric exclusion chromatography were employed for the purification of the cell culture-derived Orf virus, aiming at a maximum in virus recovery and contaminant depletion. The most promising chromatographic methods for capturing the virus particles were the steric exclusion- or salt-tolerant anion exchange membrane chromatography, recovering 84 % and 86 % of the infectious virus. Combining the steric exclusion chromatography with a subsequent Capto™ Core 700 resin or hydrophobic interaction membrane chromatography as a secondary chromatographic step, overall virus recoveries of up to 76 % were achieved. Furthermore, a complete cellular protein removal and a host cell DNA depletion of up to 82 % was possible for the steric exclusion membranes and the Capto™ Core 700 combination. The study reveals a range of possible unit operations suited for the chromatographic purification of the cell culture-derived Orf virus, depending on the intended application, i.e. a human or veterinary use, and the required purity. Elsevier B.V. 2020-11-10 2020-08-05 /pmc/articles/PMC7403136/ /pubmed/32763261 http://dx.doi.org/10.1016/j.jbiotec.2020.07.023 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Lothert, Keven Pagallies, Felix Feger, Thomas Amann, Ralf Wolff, Michael W. Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector |
title | Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector |
title_full | Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector |
title_fullStr | Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector |
title_full_unstemmed | Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector |
title_short | Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector |
title_sort | selection of chromatographic methods for the purification of cell culture-derived orf virus for its application as a vaccine or viral vector |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403136/ https://www.ncbi.nlm.nih.gov/pubmed/32763261 http://dx.doi.org/10.1016/j.jbiotec.2020.07.023 |
work_keys_str_mv | AT lothertkeven selectionofchromatographicmethodsforthepurificationofcellculturederivedorfvirusforitsapplicationasavaccineorviralvector AT pagalliesfelix selectionofchromatographicmethodsforthepurificationofcellculturederivedorfvirusforitsapplicationasavaccineorviralvector AT fegerthomas selectionofchromatographicmethodsforthepurificationofcellculturederivedorfvirusforitsapplicationasavaccineorviralvector AT amannralf selectionofchromatographicmethodsforthepurificationofcellculturederivedorfvirusforitsapplicationasavaccineorviralvector AT wolffmichaelw selectionofchromatographicmethodsforthepurificationofcellculturederivedorfvirusforitsapplicationasavaccineorviralvector |